BRENT GRASS: Open Payments
NPI 1295353183 · MASSILLON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,358 in 155 payments from 25 companies in 2025. Trend: 2023 $2,144 · 2024 $2,345 · 2025 $2,358
Food & beverage: $2,358
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $392 |
| Novo Nordisk Inc | 28 | $338 |
| PFIZER INC. | 23 | $309 |
| AstraZeneca Pharmaceuticals LP | 8 | $283 |
| GlaxoSmithKline, LLC. | 14 | $143 |
| Lilly USA, LLC | 8 | $119 |
| Optinose US, Inc. | 6 | $110 |
| Exact Sciences Corporation | 4 | $103 |
| Dexcom, Inc. | 2 | $77 |
| Phathom Pharmaceuticals, Inc. | 5 | $59 |
Products named: Ozempic, VRAYLAR, FARXIGA, NURTEC ODT, MOUNJARO, Xhance, PAXLOVID, LINZESS.
Industry payments across OH — which companies pay providers there.
